Background: A CAG repeat expansion in HTT has been known to cause Huntington's disease for over 20 years. The genomic sequence of the 67 exon HTT is clear but few reports have detailed alternative splicing or alternative transcripts. Most eukaryotic genes with multiple exons show alternative splicing that increases the diversity of the transcriptome and proteome: it would be surprising if a gene with 67 known exons in its two major transcripts did not present some alternative transcripts. Objective: To investigate the presence of alternative transcripts directly in human HTT. Methods: An overlapping RT-PCR based approach was used to determine novel HTT splice variants in human brain from HD patients and controls and 3D protein homology modelling employed to investigate their significance on the function of the HTT protein.
INTRODUCTION
Huntington's disease (HD) is an hereditary neurodegenerative disorder presenting in midlife with motor, cognitive and behavioural symptoms [1] . The Huntingtin (HTT) gene discovered over 20 years ago [2] contains the CAG repeat that when expanded causes this disorder. Studies of HD pathogenesis have largely focussed on the mutant HTT protein, or N-terminal fragments that contain the expanded polyQ, and their toxic role in cellular processes. However, the direct effect of the mutant HTT transcript has also been considered more recently [3] . RNA toxicity mechanisms are well described for some triplet-repeat diseases [4] . In CAG repeat disorders, the expanded CAG tract can lie either within the untranslated region of a gene or within the coding region; the latter case resulting in a polyQ disease [5] . In both cases the expanded CAG tract can alter the conformation of RNA leading to the formation of hairpin structures [4] . It is possible that these can mediate pathogenic effects through RNA-toxicity mechanisms including sequestration of proteins such as muscleblind-like 1 (MBNL1) and alterations to alternative splicing, effects on gene expression, mislocalisation of the transcript and repeatassociated non-ATG translation (RAN) [5] . In HD, RNA foci which sequester MBNL1 have been shown in human HD fibroblasts [6] . This could mediate effects on the splicing of transcripts in HD, including that of HTT itself.
Splicing is the process whereby introns are removed from pre-mRNA to yield a protein-encoding RNA transcript [7] and alternative splicing is a mechanism which expands the transcriptional, proteomal and phenotypic diversity of the cell and organism [8] . Most human genes are alternatively spliced [9] . Until recently, little was known about the alternative transcripts of the HTT gene and whether its encoded protein HTT exists simply as a single, or multiple protein isoforms. Sathasivam et al, 2013 reported a short HTT transcript encoding a pathogenic truncated HTT protein [10] in HD and our screen of the murine Htt gene revealed two novel splice variants either lacking exon 29 or partial retention of intron 28 [11] . Any alternative transcript of HTT has the potential to encode a novel HTT protein isoform, the function of which could differ from that of full length HTT. Here, we have extended our previous study with HD mouse models and identified novel human alternatively spliced HTT transcripts in brain material. The human HTT gene in HD and control brain regions was screened using an RT-PCR approach of overlapping amplicons spanning the entire gene. We report the existence of multiple HTT splice variants. Further in silico investigation of two splice forms not predicted to activate nonsense mediated decay (NMD) and thus having the potential to be translated, demonstrated potential functional significance for these proteins. These findings could be important for HTT biology, and the significance of the novel variants for HD pathogenesis requires further investigation.
MATERIALS AND METHODS

Cell culture
HeLa cells (human cervix epitheloid carcinoma cells; ECACC) were cultured in Dulbecco's Modified Eagle's Medium (DMEM) containing 4.5 g/L glucose and L-glutamine (Life Technologies) supplemented with 50 U/ml penicillin (Life Technologies), 50 g/ml streptomycin (Life Technologies) and 10% fetal bovine serum (FBS) (PAA). Cells were grown in a humid environment at 37
• C with 5% CO 2 and subcultured by trypsinisation in TryplE solution (Life Technologies) for 5 mins at 37
• C prior to replating in fresh medium.
Human Samples
HD patient and control cerebellum, caudate nucleus, prefrontal cortex (Brodmann area 9) and motor cortex (Brodmann area 4) samples were obtained from the New Zealand Neurological Brain Bank in accordance with the ethical principles stated in the Declaration of Helsinki (World Medical Association, 2008). Details of all samples used in this study (11 HD cases and 10 controls) are shown in Table S1 . To initially screen the HTT gene for splice variants, RNA from 4 HD patients and 4 controls from each of the four brain regions noted above was used. For the qPCR assay, RNA from 9 HD patients and 9 controls from cerebellum was used.
RNA extraction and Reverse transcription
RNA was extracted from HeLa cells and cerebellum, caudate nucleus, Brodmann area 4 and Brodmann area 9 of HD and control human brain tissue, and subject to quality to control as described in Hughes et al, 2014 [11] . Fastprep parameters were set at speed 4.5 for 25 secs for the brain material. Reverse transcription was carried out using oligo(dT) [12] [13] [14] [15] [16] [17] [18] primers as described previously [11] .
Primer design
Intron/exon boundaries of the human HTT mRNA sequence (HTT-001 ENST00000355072) were obtained from Ensembl [12] (Table S2) . Fragments of mRNA sequence were inserted into Primer 3 [13, 14] in order to design suitable amplicons 400-700 bp in size. Twenty eight sets of overlapping primers were selected (Table S3) .
PCR
PCR was carried out with BioTaq DNA polymerase according to standard protocol (Bioline) and thermocycling consisting of 30 cycles of 95
• C for 2 mins,
95
• C for 30 sec, 52-67
• C for 30 sec (see Table S2 for annealing temperatures), 72
• C for 45 sec and a final extension at 72
• C for 10 mins. PCR products were visualised using gel electrophoresis (1-2% agarose) with GelRed (Cambridge Bioscience) and a UVP documentation system. Any bands in addition to the predicted amplicon on the gel were isolated using the band stab method of Bjourson and Cooper, 1992 [15] . Re-amplification of these isolated sequences was performed by PCR as described above. DNA sequencing of isolated PCR products was performed as described previously [11] .
Taqman assays for splice variant-specific quantitative PCR
Custom Taqman assays were designed by Life Technologies for splice variants 3 and 17 (Assay ID: AJT96B4 (ex3-7); AJRR9Z0 (ex41b)) and assay Hs00918153 m1 was used to detect the exon 41-42 boundary, representative of the canonical HTT transcript. Thermocycling was performed on the 7500 real time PCR system (Life Technologies) as follows: 50
• C for 2 mins, 95 • C for 10 mins then 40 cycles of
95
• C for 15 secs, 60
• C for 1 min. For each transcript (HTT ex4,5,6; HTTex41b; HTTex41-42 (canonical)), expression levels were compared between HD patient (n = 9) and control (n = 9) cerebellum by means of a t test using a Bonferroni corrected significance level of 0.05. HTT expression levels were normalised to that of ␤-actin using Taqman assay ID: Hs99999903 m1 (Life Technologies). Data was analysed using the ddCt method [16] . Taqman assays were validated on cerebellar cDNA using standard curve.
Three-dimensional homology modelling
The 3D protein structural homology modelling was carried out using the I-TASSER server [17] for canonical wild-type HTT (ENST00000355072), in addition to SV3 (HTT ex4, 5, 6 ) and SV17 (HTTex41b). I-TASSER was also employed to predict binding sites residing within the modelled structures. Models were annotated with evolutionary sequence conservation data using ConSurf server (http://consurf.tau.ac.il/) to identify functionally important regions. For predicted binding sites only sites with a BS-score>1 were considered as this indicates a high confidence match between the template binding site and the predicted binding site. Phosphorylation sites were predicted using the NetPhos 2.0 Server [18] . All modelled structures were visualised and annotated using Chimera [19] .
Analysis of exonic variants which may modulate alternative splicing of HTT.
Using the Exome Variant Server [http://evs.gs. washington.edu/EVS/] 289 exonic variants located in the HTT gene were identified. It should be noted that only single-base substitutions within exonic regions were considered in this analysis. MutPred Splice [20] was then used to predict if any of the 289 variants were splicing sensitive and the underlying nature of any splicing mechanism disrupted (e.g. exon skipping via loss of exonic splicing enhancers or loss of natural splice site etc). High confidence splicing sensitive exonic variants were cross referenced against the reported novel alternative splicing events identified in this study, to identify exonic variants which may modulate expression levels of the alternative splicing events identified here.
RESULTS
Alternative transcripts of HTT in human brain
HTT was amplified in 28 overlapping segments spanning all HTT exons (P1-P27, Table S3 ) from cDNA derived from human cerebellum, caudate nucleus, Brodmann area 4 and Brodmann area 9 of four HD patients and four controls (For demographic information see Table S1 ). This revealed 22 alternative transcripts of HTT (Table 1) . PCR conditions for each primer set were firstly optimised using cDNA generated from HeLa cells. This was used as it provided a readily available and abundant source of human cDNA. The process showing how each variant was discovered is depicted in Fig. 1 using the examples of SV3 (HTT ex4, 5, 6) and SV17 (HTTex41b) as these were selected for further follow up due to their potential impact on HTT function. Supplementary Figure S1 shows each amplicon on agarose gels with the corresponding novel variants amplified from cerebellar or cortical cDNA. Cerebellum and Brodmann area 9 were used here as they showed the most abundant levels of splice variants when compared with the other brain regions and thus provided the best chance of isolating the novel variant from the canonical transcript by the band-stab method employed here (data not shown). All of the variants were present at lower levels than the canonical transcript ( Figure S1 ). The structure of HTT including known domains, motifs and post-translational modifications is illustrated in Fig. 2 and the predicted Fig. 1 . Subset of novel alternatively spliced transcripts identified in this study. HTT was amplified from human cerebellum cDNA and amplicons were isolated by band-stabbing, reamplified then sequenced to confirm identity. Two of the novel splice variants found (SV3 and SV17) are depicted here. SV3 (HTT ex4,5,6) was detected using primers within exon 2 (forward) and exon 8 (reverse) (primer set P2). SV17 (HTTex41b) was detected using primers within exon 40 (forward) and exon 44 (reverse) (primer set P16). The main amplicons of interest are shown. Primer sequences (P2 and P16) are detailed in Supplementary Table S3 . phenotype [26] (Fig. 2) . It is therefore feasible that any protein encoded by these RNA variants could exhibit different features to that of full length canonical HTT.
Determining expression levels of HTT alternative transcripts in HD and control brain
Of the 22 variants, the expression levels of two variants (SV3 and SV17) were assessed by quantitative PCR (qPCR). SV3 was selected for further study given the potential impact on the HTT protein of the removal of a NLS and various sites of posttranslational modification of importance. SV17 was selected as it was the only variant that would introduce a novel peptide sequence into the HTT protein.
Taqman probes designed selectively to amplify SV3 (HTT ex4,5,6) (probe spanning exons 3 to 7 and thus not detecting the canonical HTT transcript) and SV17 (HTTex41b) (probe binding the novel exon 41b sequence and thus not detecting the canonical HTT transcript) showed that these alternative transcripts were expressed in HD brain, however there was no statistically significant difference in the levels of the individual novel splice variants between HD cases and controls (SV3 p = 0.11; SV17 p = 0.09; Table 2 ).
3D structural homology modelling of novel splice variants
To identify potential functional consequences of HTT ex4,5,6 (SV3) and HTTex41b (SV17) we employed 3D structural homology modelling. These splice variants were selected for the study of expression levels and 3D modelling given their potential to impact the HTT protein as noted above. Structural homology modelling of wild type HTT encompassing exons 4, 5 and 6 (absent in HTT ex4, 5, 6 ) is shown in Fig. 3 . Exons 4, 5 and 6 (aa157-249) are predicted to encode a protein binding site (Fig. 3A) with 9 residues involved as protein-protein interaction sites (aa207, aa210, aa211, aa214, aa215, aa246, aa247, aa250, aa251). Seven of these residues occur within exons 4, 5 and 6. The predicted binding site in exons 4, 5 and 6 demonstrates a high level of homology with a binding site found in Importin subunit beta-1, a protein involved in nuclear import, which binds to five FxFG nucleoporin repeats from Nsp1p (PDB ID: 1F59; [27] ). Further supporting evidence for the predicted significance of exons 4, 5 and 6 is highlighted by the high evolutionary sequence conservation of this region (Fig. 3B) , that it is known to encode a NLS between residues aa174-207 [21] and that in its absence, post-translational modification sites of significance would be ablated (Fig. 2) . For the other splice variant Table 2 Assessment of expression levels of HTT alternative transcripts in HD (n = 9) and control (n = 9) brain by quantitative PCR. Taqman assays were used in order to amplify the canonical HTT transcript (assay Hs00918153 m1) and to exclusively amplify each unique splice variant (assays AJRR920 and AJT96B4) HTTex41b (SV17), which results in the inclusion of a novel exon (exon 41b) and thus extending the size of full length HTT, it is predicted that the novel peptide encoded by exon 41b would gain two phosphorylation sites at aaT1863 and aaS1883 (Fig. 4) .
Identification of exonic variants which may modulate expression levels of naturally occurring alternative splicing events in HTT
Outside of the splice sites, additional auxiliary cisacting elements play a crucial role in exon recognition [28] . In some cases genetic variation, both exonic and intronic, can serve to weaken (or strengthen) exon definition resulting in aberrant splicing of pre-mRNA or alternatively serve to alter expression levels of naturally occurring alternative splicing (such as exon skipping). Our focus here was exclusively on exonic variants as exonic cis-acting elements such as exonic splicing enhancers (ESE) and exonic splicing silencers (ESS) are currently much better characterized than their intronic counterparts. In silico analysis of 289 exonic variants (126 same-sense, 163 missense; MAF% 0.0078 to 25.3) within the HTT gene identified 21 variants predicted to either modulate natural alternative splicing or result in aberrant pre-mRNA splicing of HTT (Table 3) . Of these, the majority were rare variants (MAF <1%), with only one common variant found (rs2276881G>A; EA MAF% = 7.1%, AA MAF% = 1.3%). Based on the exon location of these genetic variants, it is possible that within an individual, expression levels of naturally occurring alternatively spliced transcripts could in some cases be either up or down regulated for individuals harbouring the appropriate exonic variant. Five exonic variants (rs368590997C>T, rs368866386C>T, rs3724 67345C>T, rs369912429A>G, rs371907257A>G; Table 3 ) were predicted in silico to alter the expression level of six different novel alternative splicing events identified here; HTT ex3 (SV1), HTT ex13 trunc (SV5), HTTin13 (SV6), HTT +89 in26 (SV8), HTT ex41 (SV16) and HTTex41b (SV17).
DISCUSSION
Since the discovery of the HTT gene in 1993 [2] there have been few reports supporting the existence of transcripts other than the full length canonical transcript [10, 11, 29, 30, 31] . Here, we present evidence for mul- Fig. 4 . 3D structural model of HTTex41b (residues 1201-2340). This region of HTT has an additional in-frame insertion of a novel peptide sequence encoded by a novel exon termed exon 41b (shown with green outline). Novel exon 41b is annotated with two predicted phosphorylation sites (shown in red and by asterisk on exon 41b protein sequence). The gain of two phosphorylation sites within exon 41b indicates that this splice variant is of potential functional significance.
tiple alternative splice forms of HTT in human brain. Of the 22 splice variants discovered, eight were inframe changes which were not predicted to be subject to NMD and as such could result in translated HTT protein isoforms. However, the small size difference between these splicing events could preclude the detection of the translated proteins by western blotting alone where separation from the canonical 350kDa HTT protein can prove difficult. In studies where the full length wildtype and mutant HTT has been well resolved into its 2 alleles by western blot [32] there is no evidence of these alternative proteins, which may simply reflect their relatively low abundance. It was not possible to accurately determine the abundance of these splice variants by the standard PCR approach used here, however it was noted that they were present at low levels compared to the canonical transcript ( Fig. 1 and Figure  S1 ). This finding was recapitulated for the two splice variants selected for follow up by qPCR (SV3 and SV17) given their high Ct values when compared to the canonical transcript.
Close inspection of the structure of HTT and its posttranslational modifications (Fig. 2) highlights those variants likely to exert the most significant functional effect on HTT. Splicing can affect domain architecture [8] and here, two of the most interesting variants were modelled by 3D protein homology modelling: 1) SV3, where HTT would lose its NLS, various posttranslational modification sites and a predicted ligand binding site and 2) SV17, where HTT gains a novel in-frame peptide sequence introducing two novel phosphorylation sites. For SV3, loss of a palmitoylation site in HTT could influence its normal trafficking to the Golgi and thus affect the toxicity of the HTT protein [23] . Protein phosphorylation is involved in a wide range of cellular activities including the regulation of protein function [33] and in HD, it is well established that the phosphorylation of HTT at various sites can alter its cellular toxicity [34] . Therefore for HTTex41b (SV17), the gain of two phosphorylation sites within the novel exon 41b could have important functional consequences for this putative HTT protein isoform.
Our previous study in mouse showed significantly reduced splicing in HdhQ150 mouse cerebellum compared with wild type cerebellum [11] . Investigations of HTT splicing and its significance to HD pathology are important as splicing can occur either co-transcriptionally or post-transcriptionally with the former thought to be the dominant method [35] . It is therefore possible that transcription of the mutant HTT transcript could influence its splicing and also the splicing of HTT could regulate its transcriptional activity. Moreover, RNA toxicity mechanisms have the potential to affect splicing in HD [6] . However, we did not detect any significant changes in levels of the novel splice forms between human HD and control cerebellum in this study. Given the genetic variation in humans, it is likely that substantially more samples would be needed to detect such differences. When compared with our murine study [11] it was apparent that there were many more splice variants of HTT in human brain compared with mouse brain. Even though high levels of conservation for alternative splicing between human and mouse have been reported [36] , there are more alternatively spliced transcripts in human than mouse [9, 37] . This could in part explain the differences between our studies. Non-conserved isoforms have been shown to be functional [38] so the human specific nature of these variants does not necessarily preclude their functional importance, and could reflect evolution of HTT function [39] . Even though measures were taken to ensure detection of bone fide splice variants through the generation of cDNA using polyd(T) primers to detect only polyadenylated mature transcripts, we cannot rule out the possibility that aberrant splicing may occur and so, as more RNA sequencing data is generated, it will be interesting to screen these datasets to further investigate their presence, abundance, tissue specificity and pathological significance. The 22 HTT splice variants reported here (Table 1) may not be an exhaustive list as the RT-PCR approach employed to screen for them may not have been all inclusive. Moreover, this approach would not have detected the novel variant discovered by Sathasivam et al, 2013 as it is generated by the use of a cryptic polyadenylation signal and does not involve any exon skipping events [10] . Further studies are required to confirm and validate these variants.
From the exploratory in silico analysis of exonic variants (rare mutations and common polymorphisms), it is unclear what the impact of changes to the expression levels of naturally occurring splice variants would be.
In conclusion, we have discovered multiple novel alternative splice forms of HTT in human brain with the potential to encode HTT protein isoforms which may differ in function to the full length HTT protein.
It remains to be shown whether the individual splicing events occur together in one transcript or whether several different alternative transcripts comprising combinations of these events exist. A comprehensive knowledge of all HTT RNA species is important on a number of levels. Firstly, RNA silencing therapies in HD are currently of great interest. Some approaches target specific regions of HTT RNA [40] , therefore consideration of all variants may be important in this strategy in order to silence all HTT transcripts that could encode HTT protein isoforms and interfere with phenotype. Secondly, even though a high proportion of alternative splice events result in an altered protein [41] , alternative splicing does not solely operate to generate distinct protein isoforms, but may also influence gene regulation through translation control, mRNA stability and localisation [42] . RNA variants could therefore play a role in the regulation of the HTT gene. Thirdly, these variants (or combination of inframe variants) may point to the existence of as yet unidentified HTT protein isoforms. These could contribute to a better understanding of the function of the wild type HTT protein which is yet to be fully elucidated. Of interest is the finding that splicing events can be forced to alter the structure of the HTT protein which has been shown to reduce the toxicity of the mutant HTT protein [43] . It is therefore important that the full repertoire of HTT transcripts and protein isoforms is delineated.
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